Haemonetics (HAE)
(Delayed Data from NYSE)
$90.99 USD
+3.33 (3.80%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $91.00 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 44% (142 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.83 | 1.69 | 9.99 |
Current Quarter Estimate | 0.88 | 5.88 | 60.00 |
Year Ago Quarter Estimate | 0.77 | 4.88 | 52.54 |
Next Quarter Estimate | 1.01 | 7.06 | 61.00 |
Next Year Estimate | 4.24 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 30.36 | 18.40 | 5.37 |
Next Year | 7.34 | 25.50 | 11.11 |
Last 5 Years | 9.40 | 3.70 | 8.10 |
Next 5 Years | 10.00 | 10.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 23.63 | -13.85 |
Price/Book (MRQ) | 4.89 | 1.94 |
Price/Cash Flow (MRFY) | 18.29 | 10.82 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.97% | 0.17% |
Return on Equity (TTM) | 22.37% | 8.53% |
Debt to Equity (MRQ) | NA | 22.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.